2006 NF Consortium for NF1, NF2 and Schwannomatosis

描述（由申请人提供）：本申请申请为儿童肿瘤基金会国际联盟关于NF1， NF2和神经鞘瘤病的分子和细胞生物学的2006年年会提供资金支持。会议将于2006年6月4日至7日在科罗拉多州阿斯彭的杰罗姆酒店举行。自1985年成立以来，这个年度会议已经取得了丰硕的成果，它作为NF社区研究人员和临床医生的首要年度聚会发挥着关键作用。该会议是为来自世界各地的研究人员提供研究信息交流和讨论的论坛，传统上促进了合作、共识的建立和转化研究的进展，最终实现了临床试验。从基础到临床，这是NF研究在许多方面取得巨大进展的时代，这反映在2006年会议的主题-“进步：从实验到临床”。五个单独的会议将带领联盟从NF的分子机制到转化模型到临床治疗。演讲者将包括初级和高级研究人员。为了与“从病床边到病床边”的主题保持一致，精选会议将首次包括一位生活受到NF影响的患者倡导者的几句话。每次会议还将包括由NF研究之外的主要研究者发表主题演讲，以展开广泛的讨论。有竞争力的旅行奖将邀请年轻的研究人员进行口头报告，2个海报会议将允许研究人员向NF社区展示他们的工作。2006年，我们采取了两种新方法，以提高这次会议和NF研究状况的可见度。首先，为了提高行业对NF的认识，我们将向大量制药公司寻求本次会议的财政赞助。奖励赞助将提供钻石，白金，金和银级别。其次，联合主席和基金会将共同努力，寻求在同行评议的期刊上发表一份联合报告。这将促进整个研究界了解NF研究的现状、与其他癌症和神经系统疾病的联系以及需要解决的主要障碍。

DESCRIPTION (provided by applicant): This application requests funding support for the 2006 annual meeting of the Children's Tumor Foundation International Consortium for the Molecular and Cell Biology of NF1, NF2 and Schwannomatosis. The Meeting will be held June 4-7, 2006, at the Hotel Jerome in Aspen, Colorado. This annual meeting has had a fruitful history since its inception in 1985, and it plays a lynchpin role as the premier annual gathering of researchers and clinicians in the NF community. The meeting is a forum for research information exchange and discussion for researchers from around the world, and has traditionally fostered collaboration, consensus building, and advances in translational research culminating in clinical trials. This is a time of tremendous advances in NF research on many fronts from basic through clinical, and this is reflected in the theme of the 2006 meeting - "Progress: From Bench to Bedside". Five individual sessions will take the Consortium from molecular mechanisms of NF through translational models to clinical therapies. Speakers will include both junior and senior researchers. In keeping with the bench to bedside theme, for the first time select sessions will include a few words from a patient advocate whose life is affected by NF. Each session will also include a keynote address by a leading investigator from outside of NF research to open up broad ranging discussions. Competitive travel awards will bring young investigators for oral presentations, and 2 poster sessions will allow investigators to present their work to the NF community. In 2006 we are taking two new approaches in order to increase the visibility of this meeting and of the state of NF research. Firstly to increase industry awareness of NF we will seek fiscal sponsorship for this meeting from a large number of pharmaceutical companies. Incentive sponsorships will be offered at diamond, platinum, gold and silver levels. Secondly, the co-chairs and the Foundation will work together to seek publication of a Consortium Report in a peer-reviewed journal. This will promote to the research community at large the status of NF research, the link with other cancers and neurological disorders and the key barriers to be addressed.